论文部分内容阅读
目的:探究溴己新联合头孢他啶治疗小儿肺炎临床效果。方法:选取2014年1月-2015年1月来我院就就诊的68例小儿肺炎患者为研究对象,将其分成两组,对照组使用维他命C注射液联合头孢他啶进行治疗,治疗组使用溴己新联合头孢他啶,一疗程后,观察患者治疗效果和临床症状改善时间。结果:经过治疗以后,和对照组相比,治疗组患者退烧时间、湿罗音消失时间和咳嗽好转时间较短,组间数据存在差异,具有统计学意义P<0.05。从治疗效果上来看,对照组患者总有效率为73.53%,治疗组患者为94.12%。组间数据存在差异,具有统计学意义P<0.05。结论:对小儿肺炎患者使用溴已新联合头孢他啶进行治疗,能够取得满意的临床治疗效果,值得进一步推广使用。
Objective: To investigate the clinical efficacy of bromhexine plus ceftazidime in the treatment of children pneumonia. Methods: A total of 68 children with pneumonia admitted to our hospital from January 2014 to January 2015 were enrolled in this study. Patients in the control group were treated with vitamin C injection combined with ceftazidime. The treatment group used bromhexine New joint ceftazidime, after a course of treatment, observe the patient’s treatment and clinical symptoms to improve time. Results: After treatment, compared with the control group, the patients in the treatment group had significantly shorter antipyretic time, wet rales disappearance time and cough improvement time, and there was significant difference between the two groups with statistical significance (P <0.05). From the treatment effect point of view, the control group, the total effective rate was 73.53%, the treatment group was 94.12%. Differences between the groups of data, with statistical significance P <0.05. Conclusion: The use of bromine new ceftazidime for treatment of pediatric pneumonia patients can achieve satisfactory clinical effect and is worth further promotion.